Yes, pro inflammatory signals can serve as biomarkers for cancer diagnosis, prognosis, and treatment response. Elevated levels of certain cytokines and chemokines in the blood or tumor tissue can indicate the presence of cancer and provide information about the tumor's aggressiveness. For example, high levels of IL-6 are often associated with poor prognosis in various cancers.
